{
    "title": "Celltrion launches biosimilar of AbbVie's blockbuster drug Humira in US",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12266567/Celltrion-launches-biosimilar-AbbVies-blockbuster-drug-Humira-US.html",
    "date": "2023-07-05",
    "keywords": [
        "celltrion",
        "drug",
        "humira",
        "competition",
        "yuflyma",
        "product",
        "healthcare",
        "copycat",
        "version",
        "discount",
        "blockbuster",
        "rheumatoid",
        "arthritis",
        "sale",
        "sunday",
        "company",
        "day",
        "month",
        "list",
        "price",
        "carton",
        "device",
        "autoinjector",
        "syringe",
        "interchangeability",
        "designation",
        "food",
        "administration",
        "decision",
        "quarter",
        "intervention",
        "health",
        "care",
        "professional",
        "reference",
        "boehringer",
        "ingelheim",
        "sandoz",
        "organon",
        "germanys",
        "fresenius",
        "coherus",
        "week",
        "abbvie",
        "drop",
        "prescription",
        "record",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "shilpi",
        "majumdar",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}